MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

Alexandra Valera,1 Armando López-Guillermo,1 Teresa Cardesa-Salzmann,1 Fina Climent,2 Eva González-Barca,3 Santiago Mercadal,3 Íñigo Espinosa,4 Silvana Novelli,4 Javier Briones,4 José L. Mate,5 Olga Salamero,5 Juan M. Sancho,5 Leonor Arenillas,6 Sergi Serrano,6 Nadina Erill,7 Daniel Martínez,1 Paola Castillo,1 Jordina Rovira,1 Antonio Martínez,1 Elias Campo,1 and Luis Colomo1, Grup per l’Estudi dels Limfomes de Catalunya i Balears (GELCAB)